Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials

OBJECTIVE: To review long-term certolizumab pegol (CZP) safety across all approved indications: rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), psoriasis (PSO) and Crohn’s disease (CD). METHODS: Data were pooled across 49 UCB-sponsored CZP clinical trials (27 R...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: Curtis, Jeffrey R, Mariette, Xavier, Gaujoux-Viala, Cécile, Blauvelt, Andrew, Kvien, Tore K, Sandborn, William J, Winthrop, Kevin, de Longueville, Marc, Huybrechts, Ivo, Bykerk, Vivian P
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Treatments
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560674/
https://ncbi.nlm.nih.gov/pubmed/31245056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000942
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados